Filtros de búsqueda

Lista de obras de

A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline

scientific article published on 27 November 2018

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline

artículo científico publicado en 2019

A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK

artículo científico publicado en 2020

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

artículo científico publicado en 2015

Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms

artículo científico publicado en 2020

Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide.

artículo científico publicado en 2017

Essential thrombocythaemia treated with recombinant interferon: 'real world' United Kingdom referral centre experience

scientific article published on 15 May 2019

Forging ahead or moving back: dilemmas and disappointments of novel agents for myeloproliferative neoplasms

artículo científico publicado en 2020

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

scientific article published on 07 January 2021

How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancy

artículo científico publicado en 2020

Outcomes of patients receiving direct oral anticoagulants for myeloproliferative neoplasm-associated venous thromboembolism in a large tertiary centre in the UK

artículo científico publicado en 2020

Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases

artículo científico publicado en 2019

The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis

artículo científico publicado en 2009

The impact of anemia on overall survival in patients with myelofibrosis treated with ruxolitinib in the COMFORT studies

artículo científico publicado en 2016

The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey

artículo científico publicado en 2017

UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPN

artículo científico publicado en 2019

What is pre-fibrotic myelofibrosis and how should it be managed in 2018?

artículo científico publicado en 2018